| pubmed-article:3618541 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3618541 | lifeskim:mentions | umls-concept:C0302592 | lld:lifeskim |
| pubmed-article:3618541 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:3618541 | lifeskim:mentions | umls-concept:C1512288 | lld:lifeskim |
| pubmed-article:3618541 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:3618541 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:3618541 | lifeskim:mentions | umls-concept:C0092419 | lld:lifeskim |
| pubmed-article:3618541 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:3618541 | pubmed:dateCreated | 1987-9-16 | lld:pubmed |
| pubmed-article:3618541 | pubmed:abstractText | Twenty-one evaluable patients with advanced squamous-cell cervical cancer were treated with aminothiadiazole at a dosage of 125 mg/m2 weekly. Nineteen had prior chemotherapy. One patient had a partial response; six had stable disease; 14 had increasing disease; and two were unevaluable for response. There was a single life-threatening toxic episode. Aminothiadiazole used in this dosage and schedule has minimal activity in previously treated cervical carcinoma patients. | lld:pubmed |
| pubmed-article:3618541 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3618541 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3618541 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3618541 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3618541 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3618541 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3618541 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3618541 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3618541 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3618541 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3618541 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:3618541 | pubmed:issn | 0277-3732 | lld:pubmed |
| pubmed-article:3618541 | pubmed:author | pubmed-author:MortelRR | lld:pubmed |
| pubmed-article:3618541 | pubmed:author | pubmed-author:BlessingJ AJA | lld:pubmed |
| pubmed-article:3618541 | pubmed:author | pubmed-author:HomesleyH DHD | lld:pubmed |
| pubmed-article:3618541 | pubmed:author | pubmed-author:AsburyR FRF | lld:pubmed |
| pubmed-article:3618541 | pubmed:author | pubmed-author:MalfetanoJJ | lld:pubmed |
| pubmed-article:3618541 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3618541 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:3618541 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3618541 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3618541 | pubmed:pagination | 299-301 | lld:pubmed |
| pubmed-article:3618541 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:3618541 | pubmed:meshHeading | pubmed-meshheading:3618541-... | lld:pubmed |
| pubmed-article:3618541 | pubmed:meshHeading | pubmed-meshheading:3618541-... | lld:pubmed |
| pubmed-article:3618541 | pubmed:meshHeading | pubmed-meshheading:3618541-... | lld:pubmed |
| pubmed-article:3618541 | pubmed:meshHeading | pubmed-meshheading:3618541-... | lld:pubmed |
| pubmed-article:3618541 | pubmed:meshHeading | pubmed-meshheading:3618541-... | lld:pubmed |
| pubmed-article:3618541 | pubmed:meshHeading | pubmed-meshheading:3618541-... | lld:pubmed |
| pubmed-article:3618541 | pubmed:meshHeading | pubmed-meshheading:3618541-... | lld:pubmed |
| pubmed-article:3618541 | pubmed:meshHeading | pubmed-meshheading:3618541-... | lld:pubmed |
| pubmed-article:3618541 | pubmed:meshHeading | pubmed-meshheading:3618541-... | lld:pubmed |
| pubmed-article:3618541 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3618541 | pubmed:articleTitle | Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group. | lld:pubmed |
| pubmed-article:3618541 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3618541 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:3618541 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
